Clinical Trials Logo

Nonverbal Learning Disability clinical trials

View clinical trials related to Nonverbal Learning Disability.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03553875 Recruiting - Clinical trials for Autism Spectrum Disorder

Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions

Start date: November 13, 2018
Phase: Phase 3
Study type: Interventional

This study is a 12-week randomized-controlled trial of memantine hydrochloride (Namenda) for the treatment of social impairment in youth with Non-Verbal Learning Disorder, High-Functioning Autism Spectrum Disorder, and related conditions. Eligible participants will be males and females ages 8-18. This study consists of up to 6 visits to Massachusetts General Hospital.